The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cells

FASEB Journal

Volumn 23, Issue 3, 2009, Pages 774-782

  Hohensinner, P J ^a,c   Kaun, C ^a   Rychli, K ^a   Niessner, A ^a   Pfaffenberger, S ^a   Rega, G ^a   Furnkranz, A ^d   Uhrin, P ^b   Zaujec, J ^b   Afonyushkin, T ^b   Bochkov, V N ^b   Maurer, G ^a   Huber, K ^c   Wojta, J ^a,b  

^a Department of Internal Medicine II ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Ludwig Boltzmann Cluster for Cardiovascular Research   (Austria)

^d WILHELMINEN HOSPITAL   (Austria)

Author keywords

Cytokine; Heart

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; ONCOSTATIN M; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HEART FAILURE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REGENERATION; TISSUE REPAIR; UPREGULATION;

ADULT; ANIMALS; CELLS, CULTURED; CHEMOKINE CCL1; CHEMOKINE CCL5; CHEMOKINE CXCL12; FIBROBLASTS; FLAVONOIDS; HUMANS; INFLAMMATION; LIGANDS; MALE; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; ONCOSTATIN M; TIME FACTORS; UP-REGULATION;

MURINAE; MUS;

EID: 61449247211     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.08-108035     Document Type: Article

References (51)

1. Shirozu, M., Nakano, T., Inazawa, J., Tashiro, K., Tada, H., Shinohara, T., and Honjo, T. (1995) Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28, 495-500
2. Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., and Gurtner, G. C. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10, 858-864
3. Pillarisetti, K., and Gupta, S. K. (2001) Cloning and relative expression analysis ofrat stromal cell derived factor-1 (SDF-1)1: SDF-1 alpha mRNA is selectively induced in rat model of myocardial infarction. Inflammation 25, 293-300
4. Segret, A., Rucker-Martin, C., Pavoine, C., Flavigny, J., Derou-baix, E., Chatel, M. A., Lombet, A., and Renaud, J. F. (2007) Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes. J. Histochem. Cytochem. 55, 141-150
5. Leone, A. M., Rutella, S., Bonanno, G., Contemi, A. M., de Ritis, D. G., Giannico, M. B., Rebuzzi, A. G., Leone, G., and Crea, F. (2006) Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int. J. Cardiol. 111, 202-208
6. Yamani, M. H., Ratliff, N. B., Cook, D. J., Tuzcu, E. M., Yu, Y., Hobbs, R., Rincon, G., Bott-Silverman, C., Young, J. B., Smedira, N., and Starling, R. C. (2005) Peritransplant ischemic injury is associated with up-regulation of stromal cell-derived factor-1. J. Am. Coll. Cardiol. 46, 1029-1035
7. Ma, N., Stamm, C., Kaminski, A., Li, W., Kleine, H. D., Muller-Hilke, B., Zhang, L., Ladilov, Y., Egger, D., and Steinhoff, G. (2005) Human cord blood cells induce angiogenesis following myocardial infarction in NOD/scid-mice. Cardiovasc. Res. 66, 45-54
8. Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., Rovner, A., Ellis, S. G., Thomas, J. D., DiCorleto, P. E., Topol, E. J., and Penn, M. S. (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697-703
9. Abbott, J. D., Huang, Y., Liu, D., Hickey, R., Krause, D. S., and Giordano, F. J. (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110, 3300 -3305
10. Grunewald, M., Avraham, I., Dor, Y., Bachar-Lustig, E., Itin, A., Jung, S., Chimenti, S., Landsman, L., Abramovitch, R., and Keshet, E. (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124, 175-189
11. Hu, X., Dai, S., Wu, W. J., Tan, W., Zhu, X., Mu, J., Guo, Y., Bolli, R., and Rokosh, G. (2007) Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 116, 654-663
12. Hitchon, C., Wong, K., Ma, G., Reed, J., Lyttle, D., and El-Gabalawy, H. (2002) Hypoxia-induced production of stromal cell-derived factor 1 (CXCL12) and vascular endothelial growth factor by synovial fibroblasts. Arthritis Rheum. 46, 2587-2597
13. Kim, K. W., Cho, M. L., Kim, H. R., Ju, J. H., Park, M. K., Oh, H. J., Kim, J. S., Park, S. H., Lee, S. H., and Kim, H. Y. (2007) Up-regulation of stromal cell-derived factor 1 (CXCL12) production in rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum. 56, 1076-1086
14. Kishimoto, T., Taga, T., and Akira, S. (1994) Cytokine signal transduction. Cell 76, 253-262
15. Fischer, P., and Hilfiker-Kleiner, D. (2007) Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res. Cardiol. 102, 393-411
16. Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez- Luna, J. L., Nunez, G., Dalton, W. S., and Jove, R. (1999) Constitutive activation ofStat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 10, 105-115
17. Sano, S., Itami, S., Takeda, K., Tarutani, M., Yamaguchi, Y., Miura, H., Yoshikawa, K., Akira, S., and Takeda, J. (1999) Keratinocyte-specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis. EMBO J. 18, 4657-4668
18. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379-1383
19. Brar, B. K., Stephanou, A., Pennica, D., and Latchman, D. S. (2001) CT-1 mediated cardioprotection against ischaemic re-oxygenation injury is mediated by PI3 kinase, Akt and MEK1/2 pathways. Cytokine 16, 93-96
20. Freed, D. H., Moon, M. C., Borowiec, A. M., Jones, S. C., Zahradka, P., and Dixon, I. M. (2003) Cardiotrophin-1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol. Cell. Biochem. 254, 247-256
21. Gwechenberger, M., Mendoza, L. H., Youker, K. A., Frangogiannis, N. G., Smith, C. W., Michael, L. H., and Entman, M. L. (1999) Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99, 546-551
22. Ono, K., Matsumori, A., Shioi, T., Furukawa, Y., and Sasayama, S. (1998) Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling. Circulation 98, 149-156
23. Wang, F., Trial, J., Diwan, A., Gao, F., Birdsall, H., Entman, M., Hornsby, P., Sivasubramaniam, N., and Mann, D. (2002) Regulation of cardiac fibroblast cellular function by leukemia inhibitory factor. J. Mol. Cell. Cardiol. 34, 1309-1316
24. Yue, P., Massie, B. M., Simpson, P. C., and Long, C. S. (1998) Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure. Am. J. Physiol. 275, H250-H258
25. Hirota, H., Chen, J., Betz, U. A., Rajewsky, K., Gu, Y., Ross, J., Jr., Muller, W., and Chien, K. R. (1999) Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97, 189-198
26. Weiss, T. W., Speidl, W. S., Kaun, C., Rega, G., Springer, C., Macfelda, K., Losert, U. M., Grant, S. L., Marro, M. L., Rhodes, A. D., Fuernkranz, A., Bialy, J., Ullrich, R., Holzmann, P., Pacher, R., Maurer, G., Huber, K., and Wojta, J. (2003) Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. Cardiovasc. Res. 59, 628-638
27. Macfelda, K., Weiss, T. W., Kaun, C., Breuss, J. M., Zorn, G., Oberndorfer, U., Voegele-Kadletz, M., Huber-Beckmann, R., Ullrich, R., Binder, B. R., Losert, U. M., Maurer, G., Pacher, R., Huber, K., and Wojta, J. (2002) Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators inter-leukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes. J. Mol. Cell. Cardiol. 34, 1681-1691
28. Weiss, T. W., Kvakan, H., Kaun, C., Zorn, G., Speidl, W. S., Pfaffenberger, S., Maurer, G., Huber, K., and Wojta, J. (2005) The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart. J. Mol. Cell. Cardiol. 39, 545-551
29. Lafontant, P. J., Burns, A. R., Donnachie, E., Haudek, S. B., Smith, C. W., and Entman, M. L. (2006) Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 291, C18-C26
30. Weiss, T. W., Mehrabi, M. R., Kaun, C., Zorn, G., Kastl, S. P., Speidl, W. S., Pfaffenberger, S., Rega, G., Glogar, H. D., Maurer, G., Pacher, R., Huber, K., and Wojta, J. (2004) Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism. J. Mol. Cell. Cardiol. 36, 539-546
31. Ben-Tal Cohen, E., Hohensinner, P. J., Kaun, C., Maurer, G., Huber, K., and Wojta, J. (2007) Statins decrease TNF-alpha-induced osteoprotegerin production by endothelial cells and smooth muscle cells in vitro. Biochem. Pharmacol. 73, 77-83
32. Hohensinner, P. J., Kaun, C., Rychli, K., Niessner, A., Pfaffen-berger, S., Rega, G., de Martin, R., Maurer, G., Ullrich, R., Huber, K., and Wojta, J. (2007) Macrophage colony stimulating factor expression in human cardiac cells is upregulated by tumor necrosis factor-alpha via NF-κB-dependent mechanism. J. Thromb. Haemost. 5, 2520-2528
33. Demyanets, S., Pfaffenberger, S., Kaun, C., Rega, G., Speidl, W. S., Kastl, S. P., Weiss, T. W., Hohensinner, P. J., Dietrich, W., Tschugguel, W., Bochkov, V. N., Awad, E. M., Maurer, G., Huber, K., and Wojta, J. (2006) The estrogen metabolite 17β-dihydroequilenin counteracts interleukin-1α induced expression of inflammatory mediators in human endothelial cells in vitro via NF-κB pathway. Thromb. Haemost. 95, 107-116
34. Bochkov, V. N., Mechtcheriakova, D., Lucerna, M., Huber, J., Malli, R., Graier, W. F., Hofer, E., Binder, B. R., and Leitinger, N. (2002) Oxidized phospholipids stimulate tissue factor expression in human endothelial cells via activation of ERK/EGR-1 and Ca( + + )/NFAT. Blood 99, 199-206
35. Fedyk, E. R., Jones, D., Critchley, H. O., Phipps, R. P., Blieden, T. M., and Springer, T. A. (2001) Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J. Immunol. 166, 5749-5754
36. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Muller-Newen, G., and Schaper, F. (2003) Principles of inter-leukin (IL)-6-type cytokine signalling and its regulation. Bio-chem. J. 374, 1-20
37. Elmadbouh, I., Haider, H., Jiang, S., Idris, N. M., Lu, G., and Ashraf, M. (2007) Ex vivo delivered stromal cell-derived factor-1α promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J. Mol. Cell. Cardiol. 42, 792-803
38. Zhang, M., Mal, N., Kiedrowski, M., Chacko, M., Askari, A. T., Popovic, Z. B., Koc, O. N., and Penn, M. S. (2007) SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 21, 3197-3207
39. Vandervelde, S., van Luyn, M. J., Tio, R. A., and Harmsen, M. C. (2005) Signaling factors in stem cell-mediated repair of in-farcted myocardium. J. Mol. Cell Cardiol. 39, 363-376
40. Salvucci, O., Basik, M., Yao, L., Bianchi, R., and Tosato, G. (2004) Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogene-sis by TNF-α and IFN-γ. J. Leukoc. Biol. 76, 217-226
41. Lee, M. J., Song, H. Y., Kim, M. R., Sung, S. M., Jung, J. S., and Kim, J. H. (2007) Oncostatin M stimulates expression of stro-mal-derived factor-1 in human mesenchymal stem cells. Int. J. Biochem. Cell Biol. 39, 650-659
42. Ebelt, H., Jungblut, M., Zhang, Y., Kubin, T., Kostin, S., Tech-nau, A., Oustanina, S., Niebrugge, S., Lehmann, J., Werdan, K., and Braun, T. (2007) Cellular cardiomyoplasty: improvement of left ventricular function correlates with the release of cardioactive cytokines. Stem Cells 25, 236-244
43. Tanaka, M., Hirabayashi, Y., Sekiguchi, T., Inoue, T., Katsuki, M., and Miyajima, A. (2003) Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 102, 3154-3162
44. Minehata, K., Takeuchi, M., Hirabayashi, Y., Inoue, T., Donovan, P. J., Tanaka, M., and Miyajima, A. (2006) Oncostatin M maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow. Int. J. Hematol. 84, 319-327
45. Tong, L., Smyth, D., Kerr, C., Catterall, J., and Richards, C. D. (2004) Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Cell. Signal. 16, 1123-1132
46. Sohara, N., Trojanowska, M., and Reuben, A. (2002) Oncosta-tin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts. J. Hepatol. 36, 191-199
47. Demyanets, S., Kaun, C., Rychli, K., Rega, G., Pfaffenberger, S., Afonyushkin, T., Bochkov, V. N., Maurer, G., Huber, K., and Wojta, J. (2007) The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways. Am. J. Physiol. Heart Circ. Physiol. 293, H1962-H1968
48. Amin, M. A., Mansfield, P. J., Pakozdi, A., Campbell, P. L., Ahmed, S., Martinez, R. J., and Koch, A. E. (2007) Interleu-kin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum. 56, 1787-1797
49. Modur, V., Feldhaus, M. J., Weyrich, A. S., Jicha, D. L., Prescott, S. M., Zimmerman, G. A., and Mclntyre, T. M. (1997) Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J. Clin. Invest. 100, 158-168
50. Laflamme, M. A., and Murry, C. E. (2005) Regenerating the heart. Nat. Biotechnol. 23, 845-856
51. Guan, K., and Hasenfuss, G. (2007) Do stem cells in the heart truly differentiate into cardiomyocytes? J. Mol. Cell. Cardiol. 43, 377-387